According to Zhitong Finance App, Tiger Pharmaceuticals (03347.HK) issued an announcement. As of October 30, 2026, the company has repurchased 20.963,500 shares of the company's shares through a special securities account for share repurchase through centralized bidding transactions, accounting for 2.4347% of the company's current total share capital and 2.8410% of the company's current total A-share capital. The highest transaction price was 42.78 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 824 million yuan (excluding transaction fees). This repurchase complies with the requirements of the company's share repurchase plan and related laws and regulations.

According to Zhitong Finance App, Tiger Pharmaceuticals (03347.HK) issued an announcement. As of October 30, 2026, the company has repurchased 20.963,500 shares of the company's shares through a special securities account for share repurchase through centralized bidding transactions, accounting for 2.4347% of the company's current total share capital and 2.8410% of the company's current total A-share capital. The highest transaction price was 42.78 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 824 million yuan (excluding transaction fees). This repurchase complies with the requirements of the company's share repurchase plan and related laws and regulations.